My commentary on the National Institutes of Health's Office of Scientific Integrity in the May 13, 1991, issue of The Scientist [page 12] referred to its overreaction to political pressure in combating fraud. I think it's important to add a mention of some related history. In an earlier era of red-baiting, NIH refused to award grants to such distinguished scientists as Linus Pauling and Elvin Kabat, because they were accused (without trial) of misconduct. Because most readers are probably not
Because most readers are probably not aware of that shameful history, I am grateful to The Scientist for publishing this addendum. In evaluating current reactions to congressional pressure, a concrete example of an earlier mistake may be more useful than abstract arguments.
BERNARD D. DAVIS
Microbiology Department
Harvard Medical School
Boston
Memory-enhancing neural networks may also drive involuntary musical loops in the brain.
View this Issue
In this webinar, Felix Lansing will discuss how AI-driven models improve recombinase development.
In this webinar, Brian Hie will discuss Evo2, a state-of-the-art genomic foundation model capable of generalist prediction and design tasks across DNA, RNA, and proteins.
In this webinar, learn how scientists use advanced human brain models to uncover treatment strategies for complex neurological conditions.
In the dynamic biotechnology and biopharmaceutical science fields, qPCR and dPCR multiplexing has emerged as a crucial technique for accelerated and consistent research workflows.
Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters' proven execution model
Zymo Research, a global leader in sample preparation technologies and sustainable life science solutions, will partner with Harvard University to host the BioFestival on October 18, 2025.
Ambitious study will profile thousands of tumor samples to uncover novel biomarkers and therapeutic targets for cancer and inflammatory diseases
This new product line is specifically engineered to meet the rigorous demands of immunology research, vaccine development, animal studies, cell and gene therapy, and therapeutic protein manufacturing.
